[go: up one dir, main page]

DK162385D0 - IMPLANTABLE PREPARATIONS OF REGULATORY PEPTIDES WITH MANAGED RELEASE AND PROCEDURES FOR PRODUCING THEM - Google Patents

IMPLANTABLE PREPARATIONS OF REGULATORY PEPTIDES WITH MANAGED RELEASE AND PROCEDURES FOR PRODUCING THEM

Info

Publication number
DK162385D0
DK162385D0 DK162385A DK162385A DK162385D0 DK 162385 D0 DK162385 D0 DK 162385D0 DK 162385 A DK162385 A DK 162385A DK 162385 A DK162385 A DK 162385A DK 162385 D0 DK162385 D0 DK 162385D0
Authority
DK
Denmark
Prior art keywords
procedures
producing
regulatory peptides
managed release
implantable preparations
Prior art date
Application number
DK162385A
Other languages
Danish (da)
Other versions
DK162385A (en
Inventor
Juergen Kurt Sandow
Heinz-Ruediger Seidel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK162385D0 publication Critical patent/DK162385D0/en
Publication of DK162385A publication Critical patent/DK162385A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK162385A 1984-04-11 1985-04-10 IMPLANTABLE PREPARATIONS OF REGULATORY PEPTIDES WITH MANAGED RELEASE AND PROCEDURES FOR PRODUCING THEM DK162385A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843413608 DE3413608A1 (en) 1984-04-11 1984-04-11 IMPLANTABLE PREPARATIONS OF REGULATORY PEPTIDES WITH CONTROLLED RELEASE AND METHOD FOR THE PRODUCTION THEREOF

Publications (2)

Publication Number Publication Date
DK162385D0 true DK162385D0 (en) 1985-04-10
DK162385A DK162385A (en) 1985-10-12

Family

ID=6233259

Family Applications (1)

Application Number Title Priority Date Filing Date
DK162385A DK162385A (en) 1984-04-11 1985-04-10 IMPLANTABLE PREPARATIONS OF REGULATORY PEPTIDES WITH MANAGED RELEASE AND PROCEDURES FOR PRODUCING THEM

Country Status (12)

Country Link
EP (1) EP0158277A3 (en)
JP (1) JPS60228411A (en)
KR (1) KR850007559A (en)
AU (1) AU4105985A (en)
DE (1) DE3413608A1 (en)
DK (1) DK162385A (en)
ES (1) ES8607732A1 (en)
GR (1) GR850905B (en)
HU (1) HUT40760A (en)
IL (1) IL74848A0 (en)
PT (1) PT80252B (en)
ZA (1) ZA852639B (en)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79134A (en) * 1985-07-29 1991-06-10 American Cyanamid Co Continuous release peptide implants for parenteral administration
US5137874A (en) * 1985-07-29 1992-08-11 American Cyanamid Co. Partially coated C10 -C20 fatty acid salts of peptides having molecular weights up to about 5,000
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
CA1257199A (en) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation containing bioactive macromolecular substance for multi-months release in vivo
AU601736B2 (en) * 1986-05-23 1990-09-20 Sanofi Sante Nutrition Animale Sa Coated veterinary implants
AU2902289A (en) * 1987-12-08 1989-07-05 Mark Chasin Method of forming bioerodible implants for improved controlled drug release
JP2590358B2 (en) * 1988-03-01 1997-03-12 正雄 五十嵐 In utero or vaginal administration preparation for endometriosis treatment
EP0550436A1 (en) * 1989-11-06 1993-07-14 Alkermes Controlled Therapeutics, Inc. Protein microspheres and methods of using them
CA2046830C (en) * 1990-07-19 1999-12-14 Patrick P. Deluca Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
AU692794B2 (en) 1993-08-30 1998-06-18 Baylor College Of Medicine Senescent cell-derived inhibitors of DNA synthesis
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
US5674888A (en) * 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
US6020473A (en) 1995-08-25 2000-02-01 Genentech, Inc. Nucleic acids encoding variants of vascular endothelial cell growth factor
US7005505B1 (en) 1995-08-25 2006-02-28 Genentech, Inc. Variants of vascular endothelial cell growth factor
US6100071A (en) 1996-05-07 2000-08-08 Genentech, Inc. Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
JP3860841B2 (en) * 1996-08-30 2006-12-20 ペプテック リミテッド Sustained peptide release formulation
US6475724B1 (en) 1997-01-28 2002-11-05 The Regents Of The University Of California Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US7138511B1 (en) 1997-01-28 2006-11-21 The Regents Of The University Of California Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6171788B1 (en) 1997-01-28 2001-01-09 The Regents Of The University Of California Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
EP2050762A3 (en) 1998-03-10 2009-07-08 Genentech, Inc. Human cornichon-like protein and nucleic acids encoding it
US7078382B1 (en) 1999-11-02 2006-07-18 Genentech, Inc. Modulation of eNOS activity and therapeutic uses thereof
US20040224000A1 (en) * 2003-05-05 2004-11-11 Romano Deghenghi Implants for non-radioactive brachytherapy of hormonal-insensitive cancers
JP2008514547A (en) 2004-05-23 2008-05-08 ハウシー・ファーマシューティカルズ・インコーポレーテッド Theramutein modulator
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
ES2335232T3 (en) 2005-06-21 2010-03-23 Xoma Technology Ltd. ANTIBODIES AND FRAGMENTS OF THE SAME THAT JOIN THE IL-1 BETA.
ATE480267T1 (en) * 2006-01-05 2010-09-15 Med Inst Inc ZEIN COATED MEDICAL DEVICE
CA2673592C (en) 2006-12-20 2014-03-25 Xoma Technology Ltd. Methods for the treatment of il-1.beta. related diseases
EP2190448B1 (en) 2007-06-22 2016-04-20 Children's Medical Center Corporation Methods and uses thereof of a fragment of saposin a
WO2009067431A2 (en) 2007-11-20 2009-05-28 Cook Incorporated Controlled drug delivery using a zein layer modified with levulinic acid
EP2391650B1 (en) 2007-12-20 2014-10-15 Xoma (Us) Llc Methods for the treatment of gout
WO2010144797A2 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Influenza vaccines with enhanced immunogenicity and uses thereof
CN101669899B (en) * 2009-09-29 2011-02-02 河北科技大学 Sustained-release implant taking maize protein as main framework material or matrix and use thereof
EP3925670A1 (en) 2009-12-17 2021-12-22 Children's Medical Center, Corp. Saposin-a derived peptides and uses thereof
US20130039947A1 (en) 2010-03-12 2013-02-14 Children's Medical Center Corporation Novel immunogens and methods for discovery and screening thereof
CN101843577A (en) * 2010-04-08 2010-09-29 安徽中医学院 Coating implant using zein as skeleton material and preparation method
US20130115237A1 (en) 2010-06-09 2013-05-09 Vaccine Technologies, Incorporated Therapeutic immunization in hiv infected subjects to augment antiretroviral treatment
WO2012092539A2 (en) 2010-12-31 2012-07-05 Takeda Pharmaceutical Company Limited Antibodies to dll4 and uses thereof
EP2706991B1 (en) 2011-05-11 2021-03-24 Children's Medical Center Corporation Multiple antigen presenting immunogenic composition, and methods and uses thereof
ES2664224T3 (en) 2011-08-19 2018-04-18 Children's Medical Center Corporation VEGF binding protein for angiogenesis blockade
EP3050900A1 (en) 2011-12-19 2016-08-03 Xoma (Us) Llc Methods for treating acne
EP3560509B1 (en) 2011-12-22 2024-01-31 Children's Medical Center Corporation Saposin-a derived peptides and uses thereof
US20140050720A1 (en) 2012-01-09 2014-02-20 The Scripps Research Institute Ultralong complementarity determining regions and uses thereof
CA2862979A1 (en) 2012-01-09 2013-07-18 The Scripps Research Institute Humanized antibodies with ultralong cdr3s
EP4272750A3 (en) 2013-02-07 2024-01-24 Children's Medical Center, Corp. Protein antigens that provide protection against pneumococcal colonization and/or disease
WO2015017146A2 (en) 2013-07-18 2015-02-05 Fabrus, Inc. Antibodies with ultralong complementarity determining regions
CN111518199A (en) 2013-07-18 2020-08-11 图鲁斯生物科学有限责任公司 Humanized antibodies with ultralong complementarity determining regions
KR102302634B1 (en) 2013-09-13 2021-09-14 더 스크립스 리서치 인스티튜트 Modified therapeutic agents and compositions thereof
KR102357968B1 (en) 2013-10-15 2022-02-03 더 스크립스 리서치 인스티튜트 Chimeric antigen receptor t cell switches and uses thereof
CN105829349B (en) 2013-10-15 2023-02-03 斯克利普斯研究所 Peptide chimeric antigen receptor T cell switches and uses thereof
EP3082797A4 (en) 2013-12-18 2017-12-13 The California Institute for Biomedical Research Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof
EP2977758A1 (en) 2014-07-24 2016-01-27 Université De Nice Sophia Antipolis Methods and kits for monitoring membranous nephropathy
WO2016154621A1 (en) 2015-03-26 2016-09-29 The California Institute For Biomedical Research SWITCHABLE NON-scFv CHIMERIC RECEPTORS, SWITCHES, AND USES THEREOF
EP3283113A4 (en) 2015-04-15 2018-12-05 The California Institute for Biomedical Research Optimized pne-based chimeric receptor t cell switches and uses thereof
US20190000928A1 (en) 2015-06-17 2019-01-03 The California Institute For Biomedical Research Modified therapeutic agents and compositions thereof
KR102613430B1 (en) 2016-10-19 2023-12-18 더 스크립스 리서치 인스티튜트 Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor-interacting domains and uses thereof
CA3103265A1 (en) 2018-06-12 2019-12-19 Angiex, Inc. Antibody-oligonucleotide conjugates
CN119409834A (en) 2019-08-12 2025-02-11 北京恩瑞尼生物科技股份有限公司 Methods and compositions for promoting and enhancing T cell-mediated immune responses through ADCC targeting of CD39 expressing cells
JP2022554187A (en) 2019-10-24 2022-12-28 ミノトール セラピューティクス インコーポレイテッド Chimeric cytokine-engineered antibodies and methods of use thereof
CA3217865A1 (en) 2021-04-28 2022-11-03 Minotaur Therapeutics, Inc. Humanized chimeric bovine antibodies and methods of use
TW202400647A (en) 2022-04-29 2024-01-01 美商普瑞諾生物科技公司 Methods and compositions for treating eosinophil driven diseases and disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE184774C (en) *
US2895880A (en) * 1955-05-13 1959-07-21 Smith Kline French Lab Sustained release pharmaceutical product
GB935672A (en) * 1960-07-19 1963-09-04 Sterling Drug Inc Sustained release tablet
DE2242844A1 (en) * 1972-08-31 1974-04-11 Wolfgang Joachim Guettner Zein-based aerosol spray - contg carbon dioxide propellant dissolved in solvent (mixt) for zein
HUT35524A (en) * 1983-08-02 1985-07-29 Hoechst Ag Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance

Also Published As

Publication number Publication date
EP0158277A2 (en) 1985-10-16
EP0158277A3 (en) 1987-04-29
PT80252B (en) 1987-02-03
IL74848A0 (en) 1985-07-31
PT80252A (en) 1985-05-01
ES542045A0 (en) 1986-06-01
DK162385A (en) 1985-10-12
GR850905B (en) 1985-11-25
KR850007559A (en) 1985-12-07
JPS60228411A (en) 1985-11-13
ES8607732A1 (en) 1986-06-01
DE3413608A1 (en) 1985-10-24
AU4105985A (en) 1985-10-17
HUT40760A (en) 1987-02-27
ZA852639B (en) 1985-11-27

Similar Documents

Publication Publication Date Title
DK162385D0 (en) IMPLANTABLE PREPARATIONS OF REGULATORY PEPTIDES WITH MANAGED RELEASE AND PROCEDURES FOR PRODUCING THEM
DK495585D0 (en) PHARMACEUTICAL PREPARATION WITH CONTROLLED RELEASE AND PROCEDURE FOR PRODUCING THE SAME
DK457984D0 (en) PROCEDURE FOR PREPARING DELAYED PHARMACEUTICAL PREPARATIONS
DK239489D0 (en) PROCEDURE FOR THE PREPARATION OF DIALKYLD DISULPHIDES AND POLYSULPHIDES
DK256485A (en) VETERINATED PREPARATION AND PROCEDURE FOR PREPARING THEREOF
DK164486D0 (en) MOLECULARALLY ORIENTED MATERIAL AND PROCEDURE FOR PREPARING THIS
DK546788A (en) PROCEDURE AND APPARATUS FOR THE PREPARATION OF AIRCRAFT
DK559387A (en) METHOD AND INTERMEDIATE FOR THE PREPARATION OF 3-PYRROLIDINOLS
DK314786A (en) PROCEDURE FOR PREPARING PROTEINS AND POLYPEPTIDES
DK549087A (en) GANGLIOSIDE-RELATED COMPOUNDS AND PROCEDURES FOR THE PREPARATION OF SAME
DK38493D0 (en) PROCEDURE FOR THE PREPARATION OF ALCOXYMETHYLETHER AND ALCOXYMETHYL ESTERATE DERIVATIVES OF GLYCEROLES
DK273585D0 (en) PROCEDURE FOR THE MANUFACTURE OF MEDICAL COSMETIC PREPARATIONS
DK538488A (en) POWDER-YTTRA-STABILIZED ZIRCONIUM OXIDE AND PROCEDURE FOR PREPARING THIS
DK261485D0 (en) COSMETIC PREPARATIONS AND PROCEDURES FOR THEIR PREPARATION
DK155886D0 (en) VACCINE AND PROCEDURE FOR PREPARING THIS
DK362987A (en) HEXAHYDROARYLQUINOLIZIN AND PROCEDURE FOR PREPARING THEREOF
DK591788D0 (en) PROCEDURE FOR THE PREPARATION OF ALKANSULPHONIC ACIDS AND ALKANSULPHONYL CHLORIDES
DK440281A (en) PROCEDURE FOR THE PREPARATION OF N-CARBOXYLAL COOLEDIPE Peptides AND THEIR DERIVATIVES
DK28885D0 (en) HIGH CONCENTRATED Aqueous HUMAN GAMMA INTERFERON SOLUTION AND PROCEDURE FOR PREPARING THEREOF
DK180588D0 (en) ANTI-TUMOR-EFFECTIVE PREPARATIONS AND PROCEDURES FOR THEIR PREPARATION
DK162475C (en) THERAPEUTIC PREPARATION CONTAINING HYDROGENERED ERGOTAL KALOIDS AND HEPARIN AND PROCEDURE FOR PREPARING THE PREPARATION
DK670588D0 (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF PHLEBEKTASI AND PROCEDURE FOR THE PREPARATION OF THE PREPARATION
DK585686A (en) FORM III CRYSTALS OF N-ALFA - (((S) -4-OXO-2-AZETIDINYL) CARBONYL) -L-HISTIDYL-L-PROLINAMIDE AND PROCEDURES FOR PREPARING THE CRYSTALS
DK84183A (en) BENZYLETHERERY DERIVATIVES OF PENTITES AND PROCEDURES FOR PREPARING THEREOF
DK296984A (en) 3-SUBSTITUTED-3-AMINON NITRILS AND PROCEDURE FOR THEIR PREPARATION

Legal Events

Date Code Title Description
ATS Application withdrawn
ATS Application withdrawn
PBP Patent lapsed